Received Aug 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 1 | U7788AA | IM / LL |
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | Y014090 | IM / LL |
patient inadvertently received RECOMBIVAX HB and VAXELIS on the same day/Vaxelis and Hep B given resulting in 2 Hep B doses being administered; patient inadvertently received RECOMBIVAX HB and VAXELIS on the same day; This non-serious spontaneous safety report, with reference number 02809188 (Interaction# 02809129), was received by a partner on 21-MAY-2025 and forwarded to RA on 21-MAY-2025 from a Nurse Practitioner. The reporter did not assess the causal relationship between Vaxelis and the reported events of "patient inadvertently received RECOMBIVAX HB and VAXELIS on the same day." Due to the nature of the event, the causality between the events "Extra dose administered", "Overdose" and Vaxelis was not applicable. Further information is expected. FOLLOW-UP INFORMATION for this non-serious spontaneous safety report, with reference number 02809188 (Interaction# 02809129), was received by a partner on 28-MAY-2025 and forwarded to RA on 29-MAY-2025 from a Nurse Practitioner. The reporter did not assess the causal relationship between Vaxelis and the reported events of "patient inadvertently received RECOMBIVAX HB and VAXELIS on the same day." Due to the nature of the event, the causality between the events "Extra dose administered", "Overdose" and Vaxelis was not applicable. Further information is not expected. This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 16-JUL-2025 with the following VAERS primary ID: 2842845-1. The original narrative from the sender is AS FOLLOWS: No symptomatic adverse events were reported; patient inadvertently received RECOMBIVAX HB and VAXELIS on the same day; This spontaneous report was received from a Licensed Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-May-2025, the patient inadvertently vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB),, dose number 1, (lot # and expiration date were not reported) and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Inactivated Poliovirus(VAXELIS), dose number 1, (lot # and expiration date were not reported) (accidental overdose). No adverse event was reported.; Reporter's Comments: Due to the nature of the event, the causality between the events 'Extra dose administered, Overdose' and Vaxelis was not applicable. No further information is expected.
Acquired plagiocephaly; Prophylaxis